Clinical Guest Contributors
-
Fortifying The 3 Cs With Strategic Approaches And Tools
4/25/2024
In part two of this series, the authors continue the discussion by identifying specific tools and strategies that companies can use to improve communication and collaboration.
-
Assessing The 3Cs: Does Your Organization Have The Foundation For Clinical Trial Success?
4/25/2024
In part one of this series on exploring the importance of culture, communication, and collaboration, the authors discuss the makings of a strong company foundation and offer an assessment plan meant to reveal strengths and weaknesses in those three areas.
-
Validating A Better ALS Biomarker With Coya’s Fred Grossman
4/24/2024
Coya Therapeutics President and CMO Fred Grossman, DO, FAPA discusses a potential new biomarker for ALS — 4-HNE, an oxidative stress biomarker — and how it could be more effective than the current standard, NfL.
-
For Veteran PI, Research Requires Motivation, Dedication, And CRO Support
4/23/2024
Principal investigator Dr. Luke Twelves discusses how he remained motivated to continue conducting trials and shares insights into what he thinks will inspire others to do the same.
-
Will Today’s Clinical Trial Trends Become Tomorrow’s Routine?
4/23/2024
Clinical trial trends can be divided into two groups — those related to changes in the conduct of clinical trials and those related to the changes in therapeutic areas. Will these trends hold steady as 2024 unfolds?
-
Yes, Women’s Exclusion In Clinical Trials Is Still A Problem
4/22/2024
Despite the progress made in including women in clinical trials, challenges persist. Hera Biotech CEO Somer Baburek explains why the fight for inclusion isn't over.
-
Considering The Patient Experience Is Critical To Creating A Successful ICF
4/19/2024
If an ICF is not written with the patient in mind — so that it truly facilitates an informed consent — a clinical trial runs the risk of losing viable study participants and derailing study start-up, even success.
-
$100M In Government Funding Helps, But What Can Really Be Done About Trial Diversity?
4/18/2024
Breast surgical oncologist and medical director Monique Gary, DO lists three steps to take right now to improve clinical trial patient diversity.
-
Cell & Gene Therapies: An Overview Of FDA Regulatory Considerations For 2024
4/17/2024
This article outlines key FDA regulatory developments from the past few months relevant to sponsors seeking approval of cell and gene therapies in the U.S.
-
How To Determine Country Feasibility For Cell And Gene Therapy Clinical Trials
4/17/2024
Learn how to choose the right location — globally — for your next cell and gene therapy clinical trial.